AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

Research

Drs. Wolitski and Mermin Discuss Highlights of CDC Presentations at CROI 2016 (Videos)

croi2016logo

While at the 2016 Conference on Retroviruses and Opportunistic Infections (CROI)  in Boston last week, Dr. Rich Wolitski, Acting Director of the HHS Office of HIV/AIDS and Infectious Disease Policy, had an opportunity speak with Dr. Jono Mermin, Director of the CDC’s National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, about highlights of some…

Research Update: NIH’s Dr. Dieffenbach on CROI 2016 (Video)

drcarl

As the 2016 Conference on Retroviruses and Opportunistic Infections (CROI)  came to a close in Boston on February 25, we spoke with Dr. Carl Dieffenbach, Director of the Division of AIDS at NIH’s National Institute of Allergy and Infectious Diseases (NIAID), about some of the highlights of the HIV research presented there. He notes that there…

As many as 185,000 new HIV infections in the U.S. could be prevented by expanding testing, treatment, PrEP

croi_four_senarios

Reaching the National HIV/AIDS Strategy (NHAS) targets for HIV testing and treatment and expanding the use of daily Pre-Exposure Prophylaxis (PrEP) could prevent an estimated 185,000 new HIV infections in the United States by 2020 – a 70 percent reduction in new infections, according to researchers at the Centers for Disease Control and Prevention (CDC)….

Vaginal Ring & PrEP Updates from CROI with NIH’s Dr. Carl Dieffenbach (Video)

DrDieffenbach

New scientific findings to inform HIV prevention efforts were among the key highlights shared at CROI yesterday, according to Dr. Carl Dieffenbach, Director of the Division of AIDS at NIH’s National Institute of Allergy and Infectious Diseases (NIAID). After another day full of presentations on the latest in HIV science at the 2016 Conference on…

NIH-Funded Study Finds Critical Population Adheres to PrEP with Coordinated Care

blackmsm

New findings suggest that black men who have sex with men (BMSM) with access to a novel coordinated care program can adhere to pre-exposure prophylaxis (PrEP), a medication regimen that helps prevent HIV infection in uninfected individuals. Researchers reported their results today at a press conference at the Conference on Retroviruses and Opportunistic Infections (CROI)…

NIH’s Dr. Carl Dieffenbach Shares Highlights from Start of CROI 2016 (Video)

croiday1

After the first full day of sessions at the 2016 Conference on Retroviruses and Opportunistic Infections (CROI) in Boston yesterday, February 23, we caught up with Dr. Carl Dieffenbach, Director of the Division of AIDS at NIH’s National Institute of Allergy and Infectious Diseases (NIAID), to get his take on some of the key highlights of…

Tremendous Progress Made in HIV, but Serious Disparities Remain

dbrooks_headshot

Summary: Data released at this year’s CROI meeting demonstrates need for continued focus and action. This week, I’m in Boston for the annual Conference on Retroviruses and Opportunistic Infections (CROI). It’s one of the premier scientific meetings where we hear the latest research in HIV prevention and treatment. Last year, for example, researchers presented undeniable…

NIH-Funded Study Finds Effect of PrEP on Bone Density is Reversible

nih logo

The slight loss in bone mineral density associated with HIV pre-exposure prophylaxis (PrEP) antiretroviral use is reversible in young adult patients who stop taking the drugs, according to findings presented by researchers today at the 23rd Conference on Retroviruses and Opportunistic Infections (CROI) in Boston. PrEP is an HIV prevention strategy in which at-risk HIV-negative…